COMMUNIQUÉS West-GlobeNewswire

Avis aux médias: L’Hôpital Shriners pour enfants Canada invite les médias à son tournoi de golf annuel
04/08/2025
MONTRÉAL, 04 août 2025 (GLOBE NEWSWIRE) -- Quoi : L’Hôpital Shriners pour enfants Canada convie les représentants des médias à une occasion spéciale de photos et d’entrevues dans le cadre de son tournoi de golf annuel, [...]
Media advisory: Shriners Hospitals for Children Canada Invites Media to its Annual Golf Tournament
04/08/2025
MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- What: Shriners Hospitals for Children Canada invites members of the media to attend a special photo and interview opportunity during its Annual Golf Tournament at Summerlea [...]
Dunham House to Partner with CrossMed Healthcare Staffing
04/08/2025
OMAHA, Neb., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Dunham House, a first-of-its-kind, transformational initiative for combat-wounded veterans in need of long-term residential-centered care for their wounds, will partner [...]
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
– $28.6 million of Revuforj ® (revumenib) net revenue, representing 43% growth over 1Q25 – – $36.2 million of Niktimvo™ (axatilimab-csfr) net revenue reported by Incyte in first full quarter of launch; $9.4 million in [...]
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
04/08/2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and [...]
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific [...]
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated [...]
Inspire Medical Systems, Inc. Announces Second Quarter 2025 Financial Results and Updates 2025 Outlook
04/08/2025
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally [...]
FibroGen to Report Second Quarter 2025 Financial Results
04/08/2025
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2025 financial results on Monday, August 11 after the markets close. FibroGen will also conduct a conference [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
04/08/2025
FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
04/08/2025
WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Castle Biosciences Reports Second Quarter 2025 Results
04/08/2025
Delivered Q2 2025 revenue of $86 million Q 2 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, TissueCypher ® ) increased 33% over Q 2 2024 Raising full-year 2025 revenue guidance range to $ [...]
CVRx Reports Second Quarter 2025 Financial and Operating Results
04/08/2025
MINNEAPOLIS, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference
04/08/2025
NASHVILLE, Tenn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will report second quarter 2025 financial results after the market closes on Monday, [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2025
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025
04/08/2025
RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities [...]
Ardelyx Announces Changes to the Executive Leadership Team
04/08/2025
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass [...]
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance
04/08/2025
Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven Second Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, [...]
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
04/08/2025
-CASGEVY ® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells collected across all regions; positioning the program for strong [...]

Pages